Literature DB >> 33342694

Light-up RNA aptamer signaling-CRISPR-Cas13a-based mix-and-read assays for profiling viable pathogenic bacteria.

Ting Zhang1, Wenhu Zhou2, Xiaoya Lin1, Mohammad Rizwan Khan3, Sha Deng1, Mi Zhou1, Guiping He1, Chengyong Wu4, Ruijie Deng5, Qiang He1.   

Abstract

Viable pathogenic bacteria cause serious human diseases via systemic infections and food poisoning. Herein, we constructed a light-up RNA aptamer signaling-CRISPR-Cas13a assay enabling mix-and-read detection of viable pathogenic bacteria. Directly targeting pathogen RNAs via CRISPR-Cas13a allows precisely discriminating viable bacteria from dead bacteria. We introduced a light-up RNA aptamer, Broccoli, serving as the substate of activated CRISPR-Cas13a to monitor the presence of pathogen RNAs, eliminating the need to use chemically labeled RNA substrate. Sequentially, the assay allows a reverse transcription-free, nucleic acid amplification-free, and label-free quantification of RNA targets and viable pathogenic bacteria. It could detect as low as 10 CFU of Bacillus cereus and precisely quantify viable bacteria with a content ranging from 0% to 100% in 105 CFU total bacteria. The quantification of viable bacteria allows more accurately estimating the ability of B. cereus to spoil food. The RNA assay promises its use in point-of-use detection of viable pathogens and biosafety control.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas13; Food safety; Pathogen; RNA aptamer

Mesh:

Substances:

Year:  2020        PMID: 33342694     DOI: 10.1016/j.bios.2020.112906

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  8 in total

1.  Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle.

Authors:  Shuming Sun; Han Liu; Yan Hu; Yanpeng Wang; Mingri Zhao; Yijun Yuan; Yafei Han; Yingying Jing; Jin Cui; Xiaoxiang Ren; Xiao Chen; Jiacan Su
Journal:  Bioact Mater       Date:  2022-05-27

Review 2.  Recent advances of the biological and biomedical applications of CRISPR/Cas systems.

Authors:  Yaya Wang; Chun Huang; Weiqin Zhao
Journal:  Mol Biol Rep       Date:  2022-06-15       Impact factor: 2.742

Review 3.  An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.

Authors:  Mina Roueinfar; Hayley N Templeton; Julietta A Sheng; Ka Lok Hong
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

Review 4.  Powerful CRISPR-Based Biosensing Techniques and Their Integration With Microfluidic Platforms.

Authors:  Bing Chen; Ya Li; Feng Xu; Xiaonan Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-02-23

Review 5.  CRISPR-Cas Systems-Based Bacterial Detection: A Scoping Review.

Authors:  Kasturi Selvam; Mohamad Ahmad Najib; Muhammad Fazli Khalid; Mehmet Ozsoz; Ismail Aziah
Journal:  Diagnostics (Basel)       Date:  2022-05-27

6.  A Specific and Sensitive Aptamer-Based Digital PCR Chip for Salmonella typhimurium Detection.

Authors:  Yuanjie Suo; Weihong Yin; Qiangyuan Zhu; Wenshuai Wu; Wenjian Cao; Ying Mu
Journal:  Biosensors (Basel)       Date:  2022-06-26

7.  Single-tube isothermal label-free fluorescent sensor for pathogen detection based on genetic signatures.

Authors:  Mark A Reed; Yulia V Gerasimova
Journal:  Front Chem       Date:  2022-09-01       Impact factor: 5.545

8.  Self-assembly and label-free fluorescent aptasensor based on deoxyribonucleic acid intercalated dyes for detecting lactoferrin in milk powder.

Authors:  Jiahui Liu; Tengfei Li; Hongwei Qin; Linsen Li; Mengmeng Yan; Chao Zhu; Feng Qu; A M Abd El-Aty
Journal:  Front Nutr       Date:  2022-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.